Warner Chilcott's Low-Dose FemHRT Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Company says low-dose FemHRT is "consistent" with hormone replacement therapy guidelines. The drug's second quarter launch could coincide with the introduction of Warner Chilcott's other recently approved hormone replacement therapy, Femtrace.